December 21, 2024
Loading...
You are here:  Home  >  'biotech'  -  Page 37
Latest

Putting cures on a strip: Startup makes medicines for the third world

By   /  Friday, March 2nd, 2012  /  Features, Technology  /  Comments Off on Putting cures on a strip: Startup makes medicines for the third world

An Oxnard-based startup puts medicines and nutritional supplements on easy-to-use, Listerine-like strips that dissolve in the mouth.

Latest

Amgen braces for biosimilars rules

By   /  Friday, October 7th, 2011  /  Banking & Finance, Technology, Top Stories, Tri-County Public Companies  /  Comments Off on Amgen braces for biosimilars rules

This article is only available to Business Times subscribers Subscribers: LOG IN or REGISTER for complete digital access. Not a Subscriber? SUBSCRIBE for full access to our weekly newspaper, online edition and Book of Lists. Check the STATUS of your Subscription Account.

Latest

Brave new biotech: Camarillo startup launches first products

By   /  Friday, May 27th, 2011  /  Features, Technology  /  Comments Off on Brave new biotech: Camarillo startup launches first products

PBS Biotech, a Camarillo-based startup, is bringing its first products to market.

Latest

Amgen drug shows blockbuster promise

By   /  Friday, May 20th, 2011  /  Technology, Top Stories  /  Comments Off on Amgen drug shows blockbuster promise

Putting test results behind the talk at its recent product pipeline review, Thousand Oaks-based Amgen on May 17 released promising results for the Xgeva variant of its potential blockbuster bone drug denosumab.

Latest

Beyond biologics: Amgen bets new drugs will pay dividend

By   /  Friday, May 6th, 2011  /  Banking & Finance, Features, Tri-County Public Companies  /  Comments Off on Beyond biologics: Amgen bets new drugs will pay dividend

Amgen executives believe the biotech giant will grow substantially in the next decade, pursuing drugs that treat major melanoma and bone loss.

Latest

Amgen gets sought-after FDA approval

By   /  Thursday, November 18th, 2010  /  Latest news, Technology, Tri-County Public Companies  /  Comments Off on Amgen gets sought-after FDA approval

The Food and Drug Administration has approved the use of Amgen’s bone drug denosumab in patients with certain types of cancer, Amgen announced Nov. 18.

Latest

Amgen reports earnings drop

By   /  Monday, October 25th, 2010  /  Earnings, Technology, Tri-County Public Companies  /  Comments Off on Amgen reports earnings drop

Thousand Oaks-based Amgen said Oct. 25 that third-quarter earnings fell 14 percent to $1.3 billion as revenue flatlined. Amgen is the world’s biggest biotech company and the largest private employer in the Tri-Counties. It reported adjusted earnings per share of $1.36, a decrease of 9 percent compared to the same quarter last year. Total revenue Read More →